Publications

Updated post-market surveillance (PMS) rules for medical devices in the UK: differences from the EU regulations

par Alison Dennis et Alice Matthews

Purpose limitation and data minimisation: key considerations for AI training in the life sciences sector

The use of real-world evidence data to train AI models is becoming a critical component in advancing research and drug development. We explore how two of the GDPR's guiding principles are more than just regulatory requirements.

3 de 10 Publications

The UPC: a new rocket docket for life sciences patent litigation

par Dr Paul England

Orphan drug protection: clarification needed

par Dr Paul England

Life sciences M&A roundup: October 2024

par Ross McNaughton et Sarah Cole

Life sciences M&A roundup: September 2024

par Ross McNaughton et Sarah Cole

UK government launches new Regulatory Innovation Office to reduce red tape

par Debbie Heywood

Spotlight on medical devices: FDA, MHRA and EU Commission approaches to medical device regulations

par Nicholas Vollers

Regulatory Update: Microplastics and Medical Devices

Advertising medical devices - lack of harmonisation across Europe

par Alice Matthews

Electronic instructions for use for medical devices

par Ennio Schwind, LL.M. Eur.

Labelling requirements for medical devices under the new EU Product Safety Regulation